Loading...

HLN

Haleon PLC Sponsored ADR · NYSE

Performance

-1.77%

1W

+0.97%

1M

-2.35%

3M

+2.9%

6M

+2.4%

YTD

+4.21%

1Y

Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Weybridge, the United Kingdom.

Investment Analysis Report: HLN

Overview

In this investment analysis report, we will delve into a comprehensive evaluation of HLN, a company operating in the Distribution Services sector within the Medical Distributors industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operatin...

See more ...

Technical Analysis of HLN 2024-05-31

Overview:

In analyzing the technical indicators for HLN stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide inv...

See more ...

Recent News & Updates